References
- Ceckler T.L., Gibson S.L., Hilf R., Bryant R.G. In situ assessment of tumour vascularity using fluorine NMR imaging. Magnetic Resonance in Medicine 1990; 13: 416–433
- Jain R.K. Determinants of tumour blood flow: a review. Cancer Research 1988; 48: 2641–2658
- Jain R.K. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumours. Cancer Research 1990; 50: 814–819
- Jirtle R.L. Chemical modification of tumour blood flow. International Journal of Hyperthermia 1988; 4: 355–371
- Kim S.G., Ackerman J.J.H. Quantification of regional blood flow by exogenous tracer via nuclear magnetic resonance spectroscopy. Magnetic Resonance in Medicine 1990; 14: 266–282
- Long D.C., Riess J.G., Follana R., Burgan A.R., Mattrey R.F., Long D.M. Preparation and applications of highly concentrated PFOB emulsions. Biomaterials, Artificial Cells and Artificial Organs 1988; 16: 441–442
- Stratford I.J., Godden J., Howells N., Embling P., Adams G.E. (1987) Manipulation of tumour oxygenation by hydralazine increases the potency of biore-ductive radiosensitizers and enhances the effect of melphalan in experimental tumours. Radiation Research. Proceedings of the 8th International Congress of Radiation Research, Edinburgh, July, 1987, E.M. Fielden, J.F. Fowler, J.H. Hendry, D. Scott. Taylor & Francis, London, 2: 737–742
- Thomas C., Reiss J., Guichard M. Influence of the 100% w/v perfluorocotyl-bromide (PFOB) emulsion dose on tumour radiosensitivity. International Journal of Radiation Biology 1991; 59: 433–445